Vivani Medical, Inc.VANINASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-5.04%
↓ 125% below average
Average (39q)
20.09%
Historical baseline
Range
High:597.85%
Low:-80.65%
CAGR
-1.1%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -5.04% |
| Q2 2025 | 12.85% |
| Q1 2025 | -1.86% |
| Q4 2024 | 2.24% |
| Q3 2024 | 19.64% |
| Q2 2024 | -5.72% |
| Q1 2024 | -20.86% |
| Q4 2023 | 6.01% |
| Q3 2023 | 14.93% |
| Q2 2023 | -2.30% |
| Q1 2023 | -10.66% |
| Q4 2022 | 14.72% |
| Q3 2022 | 20.48% |
| Q2 2022 | 19.56% |
| Q1 2022 | -9.95% |
| Q4 2021 | 3.73% |
| Q3 2021 | 4.18% |
| Q2 2021 | 14.42% |
| Q1 2021 | 23.57% |
| Q4 2020 | 597.85% |
| Q3 2020 | -62.90% |
| Q2 2020 | -80.65% |
| Q1 2020 | -23.71% |
| Q4 2019 | 50.78% |
| Q3 2019 | -1.66% |
| Q2 2019 | 57.40% |
| Q1 2019 | -10.46% |
| Q4 2018 | -8.76% |
| Q3 2018 | 10.32% |
| Q2 2018 | -2.10% |
| Q1 2018 | 8.94% |
| Q4 2017 | 24.37% |
| Q3 2017 | -6.31% |
| Q2 2017 | 5.52% |
| Q1 2017 | -11.24% |
| Q4 2016 | 31.05% |
| Q3 2016 | 73.36% |
| Q2 2016 | 20.21% |
| Q1 2016 | 39.42% |
| Q4 2015 | -7.80% |